Article
Clonal architecture of FLT3-ITD and acquired 13q uniparental disomy define prognostic heterogeneity and therapeutic vulnerabilities in acute myeloid leukemia.
Neoplasia (New York, N.Y.) - 1 Feb 2026
Lai Anli, Liu Wenbing, Mei Yihan, Zhang Qimin, Zhang Junping, Tang Kejing, Rao Qing, Gu Runxia, Feng Sizhou, Wang Ying, Wang Min, Wei Hui, Mi Yingchang, Qiu Shaowei, Wang Jianxiang
Abstract excerpt
Acute myeloid leukemia (AML) is characterized by the sequential accumulation of genetic mutations in hematopoietic stem/progenitor cells (HSPCs). The FLT3-ITD mutation, occurring in 20-30 % of AML cases, typically emerges as a late event. Despite its established association with adverse prognosis, significant outcome heterogeneity persists in FLT3-ITD AML. The clonal origin of FLT3-ITD may serve as a critical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
